T1 Condition 479 484 virus
T2 Condition 1235 1240 tumor
T3 Level 841 890 supernatants from ICOVIR-15K-cBiTE–infected cells
T4 Intervention 519 525 T-cell
T5 Level 1457 1464 T cells
T7 Condition 197 202 virus
T8 Level 402 409 T cells
T10 Level 404 408 cell
T11 Protein 794 799 cBiTE
T12 Protein 1408 1413 cBiTE
T13 Condition 1161 1188 cBiTE-expressing adenovirus
T15 Condition 1587 1592 virus
T17 Condition 1482 1487 tumor
T18 Level 192 217 adenovirus-infected cells
T19 Protein 1001 1006 cBiTE
T20 Level 212 216 cell
T21 Condition 91 96 virus
T22 Condition 1352 1367 tumor xenograft
T23 Condition 102 108 cancer
T25 Protein 298 301 CTL
T26 Protein 639 644 cBiTE
T28 Protein 737 742 cBiTE
T29 Gene 645 654  antibody
T30 Protein 1161 1166 cBiTE
T31 Condition 1135 1140 tumor
T32 Level 1047 1051 cell
T33 Level 1256 1260 cell
T34 Protein 726 742 ICOVIR-15K-cBiTE
T36 Condition 567 588 adenovirus ICOVIR-15K
T38 Level 967 971 cell
T39 Level 383 409 tumor-infiltrating T cells
T40 Protein 859 875 ICOVIR-15K-cBiTE
T41 Protein 1397 1413 ICOVIR-15K-cBiTE
T42 Protein 990 1006 ICOVIR-15K-cBiTE
T44 Gene 1599 1605  BiTE 
T45 Condition 474 486 adenoviruses
T46 Condition 1352 1357 tumor
T47 Condition 1298 1303 virus
T48 Condition 86 98 adenoviruses
T49 Condition 1582 1594 adenoviruses
T50 Gene 909 914 BiTEs
T51 Level 885 889 cell
T52 Level 1093 1097 cell
T53 Condition 383 388 tumor
T54 Level 260 296 infiltrating cytotoxic T lymphocytes
T55 Level 1235 1261 tumor-infiltrating T cells
T56 Intervention 1130 1142 intratumoral
T57 Gene 793 800  cBiTE 
T58 Level 1448 1452 cell
T60 Level 1397 1453 ICOVIR-15K-cBiTE with peripheral blood mononuclear cells
T62 Gene 680 699 major late promoter
T63 Intervention 1045 1051 T-cell
T64 Level 1478 1487 antitumor
T65 Intervention 508 534 bispecific T-cell–engager 
T66 Gene 540 551  antibodies
R1 Relation Arg1:T21 Arg2:T48
